Sofie Dhaese (@sofie_dhaese) profile picture

Nephrologist @AZ Sint-Jan Brugge | boysmom | seafood lover | @GlomCon graduate | ERKNet postgraduate fellow | #Nephtwitter

Bruges, Belgium
Joined December 2017
Photo by Sofie Dhaese (@sofie_dhaese)Photo by Sofie Dhaese (@sofie_dhaese)Photo by Sofie Dhaese (@sofie_dhaese)Photo by Sofie Dhaese (@sofie_dhaese)Photo by Sofie Dhaese (@sofie_dhaese)Photo by Sofie Dhaese (@sofie_dhaese)
Confidence trial is out🙈 #ERA25
2
182
Preparing a GLP-1 and CKD talk. So many questions left. What about patients with proteinuria but without obesity or diabetes? What about obese patients with diabetes but without proteinuria? Have we looked into body composition and CKD risk instead of BMI or kg body weight only?
80
Membranous nephropathy (MN) in the transplant is- 1. Recurrent, mostly PLA2R+ or 2. De novo, associated with antibody mediated rejection, mostly FAT1+ We present an unusual case of de novo MN, which was Exostosin + & negative for all other antigens doi.org/10.1016/j.ekir.2024.…
1
23
1
69
4,125
Sportieve verbroedering op #ERA24 #Stockholm!
4
80
Sofie Dhaese retweeted
Replying to @sofie_dhaese
@sofie_dhaese views to manage infections in patients with renal failure #LIVES2023 @ESICM Important messages here are: ✅dose to kill different from dose to avoid selection of resistant strains ✅attractive option: reach the maximum tolerated dose! How to manage that?
1
1
109
Sofie Dhaese retweeted
👏 Great talk @sofie_dhaese ➕➕➕ My take home message here is crystal clear: 🙏Don’t decrease the dose only because the patient has renal failure! The risk of undertreatment is important and the risk of dose dependent toxicity unsure! #LIVES2023 @ESICM
1
111
Sofie Dhaese retweeted
What an intense morning! Enjoy your meal, everyone! I’ll be back for « Infections in challenging patients » 🤩 at 14h in space 2 #LIVES2023 with @jeroenschouten3 @criticcaredoc @sofie_dhaese @ESICM
1
2
195
Quick break before we start our thematic session @ESICM lives 2023 #infectionsinrenalfailure looking forward to it! #nephrology
3
103
📢Publication alert: American Society of Hematology 2023 Guidelines for Management of Venous Thromboembolism: Thrombophilia Testing ashpublications.org/bloodadv…
3
60
4
116
22,300
Oral anticoagulation in AF patients with advanced CKD. Yes, no, or maybe a little bit? Looking forward to SACK trial and @TRACK_trial! sciencedirect.com/science/ar…
1
3
170
First day as a nephrologist back in Belgium and guess what, the patient comes from the Netherlands! Fortunately I’ve mastered the Dutch accent (and many other things) during my stay @radboudumc dept of Nephrology. Big thanks and hope to visit Nijmegen again soon!!
5
258
Sofie Dhaese retweeted
🚨Register now for our next Journal Club! Topic: Direct oral anticoagulants versus warfarin in patients with non-valvular atrial fibrillation and CKD G3-G5D doi.org/10.1093/ckj/sfad004 📅Thursday 30 March 🕖5 to 6 PM CEST 🆓registration: bit.ly/3IVMCZp
5
1
13
5,279
#RT @aHUSAllianceAct: RT @aHUSUKvoice: Treatment withdrawal for #aHUS when and how? Big questions needing big answers. @KIReports doi.org/10.1016/j.ekir.2022.…
9
18
2,947
👇great #NephJC on new data that piptazo isn't nephrotoxic👏 *both* cefepime & metronidazole can promote delirium (new section on metronidazole-induced encephalopathy @ IBNCC tinyurl.com/f6a52ym2) changing from piptazo to cefepime+metronidazole is *not* good for the brain🧠
Welcome to #TenTweetNephJC tweetorial ✳️ 10 tweets to catch-up with #NephJC ✳️ Have you ever prescribed piperacillin-tazobactam? Or avoided it due to fear of causing AKI? Read on to learn more about the ‘nephrotoxin’ versus ‘pseudonephrotoxin’ debate
3
18
34
Both Piperacillin & Tazobactam are substrates for OAT1&3, the organic anion transporters, & Vancomycin suppresses expression of these pumps. Is rise in creatinine reflective of true renal injury? #NephJC
2
17
1
62
Nephrology team’s reaction when the primary team orders a PLA2R ab before placing the consult for nephrotic syndrome #nephrocentric – at Metairie, LA
11
15
1
211
Sofie Dhaese retweeted
⚡️Are you a nephrology fellow or an early career nephrologist? GlomCon accepts applications for the third class of its virtual glomerular disease fellowship. Work with an elite group of expert faculty. Learn, teach and network! Apply now at edu.glomcon.org
5
71
8
147